Global Soft Capsules Drugs CMO Market Research Report 2024(Status and Outlook)
Report Overview
The company supply Softgel Capsule contract pharmaceutical manufacturing services
The global Soft Capsules Drugs CMO market size was estimated at USD 7651 million in 2023 and is projected to reach USD 10765.73 million by 2030, exhibiting a CAGR of 5.00% during the forecast period.
North America Soft Capsules Drugs CMO market size was USD 1993.63 million in 2023, at a CAGR of 4.29% during the forecast period of 2024 through 2030.
This report provides a deep insight into the global Soft Capsules Drugs CMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Soft Capsules Drugs CMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Soft Capsules Drugs CMO market in any manner.
Global Soft Capsules Drugs CMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Catalent
Aenova
Nature's Bounty
Procaps
Patheon (Thermo Fisher Scientific)
IVC
EuroCaps
Captek
Strides Pharma Science
Lonza (Capsugel)
Soft Gel Technologies
Sirio Pharma
Market Segmentation (by Type)
Gelatin Type
Non-animal Type
Market Segmentation (by Application)
Health Supplements
Pharmaceutical
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Soft Capsules Drugs CMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 12 is the main points and conclusions of the report.
The company supply Softgel Capsule contract pharmaceutical manufacturing services
The global Soft Capsules Drugs CMO market size was estimated at USD 7651 million in 2023 and is projected to reach USD 10765.73 million by 2030, exhibiting a CAGR of 5.00% during the forecast period.
North America Soft Capsules Drugs CMO market size was USD 1993.63 million in 2023, at a CAGR of 4.29% during the forecast period of 2024 through 2030.
This report provides a deep insight into the global Soft Capsules Drugs CMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Soft Capsules Drugs CMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Soft Capsules Drugs CMO market in any manner.
Global Soft Capsules Drugs CMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Catalent
Aenova
Nature's Bounty
Procaps
Patheon (Thermo Fisher Scientific)
IVC
EuroCaps
Captek
Strides Pharma Science
Lonza (Capsugel)
Soft Gel Technologies
Sirio Pharma
Market Segmentation (by Type)
Gelatin Type
Non-animal Type
Market Segmentation (by Application)
Health Supplements
Pharmaceutical
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Soft Capsules Drugs CMO Market
- Overview of the regional outlook of the Soft Capsules Drugs CMO Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Soft Capsules Drugs CMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Soft Capsules Drugs CMO
1.2 Key Market Segments
1.2.1 Soft Capsules Drugs CMO Segment by Type
1.2.2 Soft Capsules Drugs CMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SOFT CAPSULES DRUGS CMO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Soft Capsules Drugs CMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Soft Capsules Drugs CMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SOFT CAPSULES DRUGS CMO MARKET COMPETITIVE LANDSCAPE
3.1 Global Soft Capsules Drugs CMO Sales by Manufacturers (2019-2024)
3.2 Global Soft Capsules Drugs CMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Soft Capsules Drugs CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Soft Capsules Drugs CMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Soft Capsules Drugs CMO Sales Sites, Area Served, Product Type
3.6 Soft Capsules Drugs CMO Market Competitive Situation and Trends
3.6.1 Soft Capsules Drugs CMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Soft Capsules Drugs CMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 SOFT CAPSULES DRUGS CMO INDUSTRY CHAIN ANALYSIS
4.1 Soft Capsules Drugs CMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SOFT CAPSULES DRUGS CMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 SOFT CAPSULES DRUGS CMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Soft Capsules Drugs CMO Sales Market Share by Type (2019-2024)
6.3 Global Soft Capsules Drugs CMO Market Size Market Share by Type (2019-2024)
6.4 Global Soft Capsules Drugs CMO Price by Type (2019-2024)
7 SOFT CAPSULES DRUGS CMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Soft Capsules Drugs CMO Market Sales by Application (2019-2024)
7.3 Global Soft Capsules Drugs CMO Market Size (M USD) by Application (2019-2024)
7.4 Global Soft Capsules Drugs CMO Sales Growth Rate by Application (2019-2024)
8 SOFT CAPSULES DRUGS CMO MARKET SEGMENTATION BY REGION
8.1 Global Soft Capsules Drugs CMO Sales by Region
8.1.1 Global Soft Capsules Drugs CMO Sales by Region
8.1.2 Global Soft Capsules Drugs CMO Sales Market Share by Region
8.2 North America
8.2.1 North America Soft Capsules Drugs CMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Soft Capsules Drugs CMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Soft Capsules Drugs CMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Soft Capsules Drugs CMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Soft Capsules Drugs CMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Catalent
9.1.1 Catalent Soft Capsules Drugs CMO Basic Information
9.1.2 Catalent Soft Capsules Drugs CMO Product Overview
9.1.3 Catalent Soft Capsules Drugs CMO Product Market Performance
9.1.4 Catalent Business Overview
9.1.5 Catalent Soft Capsules Drugs CMO SWOT Analysis
9.1.6 Catalent Recent Developments
9.2 Aenova
9.2.1 Aenova Soft Capsules Drugs CMO Basic Information
9.2.2 Aenova Soft Capsules Drugs CMO Product Overview
9.2.3 Aenova Soft Capsules Drugs CMO Product Market Performance
9.2.4 Aenova Business Overview
9.2.5 Aenova Soft Capsules Drugs CMO SWOT Analysis
9.2.6 Aenova Recent Developments
9.3 Nature's Bounty
9.3.1 Nature's Bounty Soft Capsules Drugs CMO Basic Information
9.3.2 Nature's Bounty Soft Capsules Drugs CMO Product Overview
9.3.3 Nature's Bounty Soft Capsules Drugs CMO Product Market Performance
9.3.4 Nature's Bounty Soft Capsules Drugs CMO SWOT Analysis
9.3.5 Nature's Bounty Business Overview
9.3.6 Nature's Bounty Recent Developments
9.4 Procaps
9.4.1 Procaps Soft Capsules Drugs CMO Basic Information
9.4.2 Procaps Soft Capsules Drugs CMO Product Overview
9.4.3 Procaps Soft Capsules Drugs CMO Product Market Performance
9.4.4 Procaps Business Overview
9.4.5 Procaps Recent Developments
9.5 Patheon (Thermo Fisher Scientific)
9.5.1 Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Basic Information
9.5.2 Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Product Overview
9.5.3 Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Product Market Performance
9.5.4 Patheon (Thermo Fisher Scientific) Business Overview
9.5.5 Patheon (Thermo Fisher Scientific) Recent Developments
9.6 IVC
9.6.1 IVC Soft Capsules Drugs CMO Basic Information
9.6.2 IVC Soft Capsules Drugs CMO Product Overview
9.6.3 IVC Soft Capsules Drugs CMO Product Market Performance
9.6.4 IVC Business Overview
9.6.5 IVC Recent Developments
9.7 EuroCaps
9.7.1 EuroCaps Soft Capsules Drugs CMO Basic Information
9.7.2 EuroCaps Soft Capsules Drugs CMO Product Overview
9.7.3 EuroCaps Soft Capsules Drugs CMO Product Market Performance
9.7.4 EuroCaps Business Overview
9.7.5 EuroCaps Recent Developments
9.8 Captek
9.8.1 Captek Soft Capsules Drugs CMO Basic Information
9.8.2 Captek Soft Capsules Drugs CMO Product Overview
9.8.3 Captek Soft Capsules Drugs CMO Product Market Performance
9.8.4 Captek Business Overview
9.8.5 Captek Recent Developments
9.9 Strides Pharma Science
9.9.1 Strides Pharma Science Soft Capsules Drugs CMO Basic Information
9.9.2 Strides Pharma Science Soft Capsules Drugs CMO Product Overview
9.9.3 Strides Pharma Science Soft Capsules Drugs CMO Product Market Performance
9.9.4 Strides Pharma Science Business Overview
9.9.5 Strides Pharma Science Recent Developments
9.10 Lonza (Capsugel)
9.10.1 Lonza (Capsugel) Soft Capsules Drugs CMO Basic Information
9.10.2 Lonza (Capsugel) Soft Capsules Drugs CMO Product Overview
9.10.3 Lonza (Capsugel) Soft Capsules Drugs CMO Product Market Performance
9.10.4 Lonza (Capsugel) Business Overview
9.10.5 Lonza (Capsugel) Recent Developments
9.11 Soft Gel Technologies
9.11.1 Soft Gel Technologies Soft Capsules Drugs CMO Basic Information
9.11.2 Soft Gel Technologies Soft Capsules Drugs CMO Product Overview
9.11.3 Soft Gel Technologies Soft Capsules Drugs CMO Product Market Performance
9.11.4 Soft Gel Technologies Business Overview
9.11.5 Soft Gel Technologies Recent Developments
9.12 Sirio Pharma
9.12.1 Sirio Pharma Soft Capsules Drugs CMO Basic Information
9.12.2 Sirio Pharma Soft Capsules Drugs CMO Product Overview
9.12.3 Sirio Pharma Soft Capsules Drugs CMO Product Market Performance
9.12.4 Sirio Pharma Business Overview
9.12.5 Sirio Pharma Recent Developments
10 SOFT CAPSULES DRUGS CMO MARKET FORECAST BY REGION
10.1 Global Soft Capsules Drugs CMO Market Size Forecast
10.2 Global Soft Capsules Drugs CMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Soft Capsules Drugs CMO Market Size Forecast by Country
10.2.3 Asia Pacific Soft Capsules Drugs CMO Market Size Forecast by Region
10.2.4 South America Soft Capsules Drugs CMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Soft Capsules Drugs CMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Soft Capsules Drugs CMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Soft Capsules Drugs CMO by Type (2025-2030)
11.1.2 Global Soft Capsules Drugs CMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Soft Capsules Drugs CMO by Type (2025-2030)
11.2 Global Soft Capsules Drugs CMO Market Forecast by Application (2025-2030)
11.2.1 Global Soft Capsules Drugs CMO Sales (K Units) Forecast by Application
11.2.2 Global Soft Capsules Drugs CMO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Soft Capsules Drugs CMO
1.2 Key Market Segments
1.2.1 Soft Capsules Drugs CMO Segment by Type
1.2.2 Soft Capsules Drugs CMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SOFT CAPSULES DRUGS CMO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Soft Capsules Drugs CMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Soft Capsules Drugs CMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SOFT CAPSULES DRUGS CMO MARKET COMPETITIVE LANDSCAPE
3.1 Global Soft Capsules Drugs CMO Sales by Manufacturers (2019-2024)
3.2 Global Soft Capsules Drugs CMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Soft Capsules Drugs CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Soft Capsules Drugs CMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Soft Capsules Drugs CMO Sales Sites, Area Served, Product Type
3.6 Soft Capsules Drugs CMO Market Competitive Situation and Trends
3.6.1 Soft Capsules Drugs CMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Soft Capsules Drugs CMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 SOFT CAPSULES DRUGS CMO INDUSTRY CHAIN ANALYSIS
4.1 Soft Capsules Drugs CMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SOFT CAPSULES DRUGS CMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 SOFT CAPSULES DRUGS CMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Soft Capsules Drugs CMO Sales Market Share by Type (2019-2024)
6.3 Global Soft Capsules Drugs CMO Market Size Market Share by Type (2019-2024)
6.4 Global Soft Capsules Drugs CMO Price by Type (2019-2024)
7 SOFT CAPSULES DRUGS CMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Soft Capsules Drugs CMO Market Sales by Application (2019-2024)
7.3 Global Soft Capsules Drugs CMO Market Size (M USD) by Application (2019-2024)
7.4 Global Soft Capsules Drugs CMO Sales Growth Rate by Application (2019-2024)
8 SOFT CAPSULES DRUGS CMO MARKET SEGMENTATION BY REGION
8.1 Global Soft Capsules Drugs CMO Sales by Region
8.1.1 Global Soft Capsules Drugs CMO Sales by Region
8.1.2 Global Soft Capsules Drugs CMO Sales Market Share by Region
8.2 North America
8.2.1 North America Soft Capsules Drugs CMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Soft Capsules Drugs CMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Soft Capsules Drugs CMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Soft Capsules Drugs CMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Soft Capsules Drugs CMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Catalent
9.1.1 Catalent Soft Capsules Drugs CMO Basic Information
9.1.2 Catalent Soft Capsules Drugs CMO Product Overview
9.1.3 Catalent Soft Capsules Drugs CMO Product Market Performance
9.1.4 Catalent Business Overview
9.1.5 Catalent Soft Capsules Drugs CMO SWOT Analysis
9.1.6 Catalent Recent Developments
9.2 Aenova
9.2.1 Aenova Soft Capsules Drugs CMO Basic Information
9.2.2 Aenova Soft Capsules Drugs CMO Product Overview
9.2.3 Aenova Soft Capsules Drugs CMO Product Market Performance
9.2.4 Aenova Business Overview
9.2.5 Aenova Soft Capsules Drugs CMO SWOT Analysis
9.2.6 Aenova Recent Developments
9.3 Nature's Bounty
9.3.1 Nature's Bounty Soft Capsules Drugs CMO Basic Information
9.3.2 Nature's Bounty Soft Capsules Drugs CMO Product Overview
9.3.3 Nature's Bounty Soft Capsules Drugs CMO Product Market Performance
9.3.4 Nature's Bounty Soft Capsules Drugs CMO SWOT Analysis
9.3.5 Nature's Bounty Business Overview
9.3.6 Nature's Bounty Recent Developments
9.4 Procaps
9.4.1 Procaps Soft Capsules Drugs CMO Basic Information
9.4.2 Procaps Soft Capsules Drugs CMO Product Overview
9.4.3 Procaps Soft Capsules Drugs CMO Product Market Performance
9.4.4 Procaps Business Overview
9.4.5 Procaps Recent Developments
9.5 Patheon (Thermo Fisher Scientific)
9.5.1 Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Basic Information
9.5.2 Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Product Overview
9.5.3 Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Product Market Performance
9.5.4 Patheon (Thermo Fisher Scientific) Business Overview
9.5.5 Patheon (Thermo Fisher Scientific) Recent Developments
9.6 IVC
9.6.1 IVC Soft Capsules Drugs CMO Basic Information
9.6.2 IVC Soft Capsules Drugs CMO Product Overview
9.6.3 IVC Soft Capsules Drugs CMO Product Market Performance
9.6.4 IVC Business Overview
9.6.5 IVC Recent Developments
9.7 EuroCaps
9.7.1 EuroCaps Soft Capsules Drugs CMO Basic Information
9.7.2 EuroCaps Soft Capsules Drugs CMO Product Overview
9.7.3 EuroCaps Soft Capsules Drugs CMO Product Market Performance
9.7.4 EuroCaps Business Overview
9.7.5 EuroCaps Recent Developments
9.8 Captek
9.8.1 Captek Soft Capsules Drugs CMO Basic Information
9.8.2 Captek Soft Capsules Drugs CMO Product Overview
9.8.3 Captek Soft Capsules Drugs CMO Product Market Performance
9.8.4 Captek Business Overview
9.8.5 Captek Recent Developments
9.9 Strides Pharma Science
9.9.1 Strides Pharma Science Soft Capsules Drugs CMO Basic Information
9.9.2 Strides Pharma Science Soft Capsules Drugs CMO Product Overview
9.9.3 Strides Pharma Science Soft Capsules Drugs CMO Product Market Performance
9.9.4 Strides Pharma Science Business Overview
9.9.5 Strides Pharma Science Recent Developments
9.10 Lonza (Capsugel)
9.10.1 Lonza (Capsugel) Soft Capsules Drugs CMO Basic Information
9.10.2 Lonza (Capsugel) Soft Capsules Drugs CMO Product Overview
9.10.3 Lonza (Capsugel) Soft Capsules Drugs CMO Product Market Performance
9.10.4 Lonza (Capsugel) Business Overview
9.10.5 Lonza (Capsugel) Recent Developments
9.11 Soft Gel Technologies
9.11.1 Soft Gel Technologies Soft Capsules Drugs CMO Basic Information
9.11.2 Soft Gel Technologies Soft Capsules Drugs CMO Product Overview
9.11.3 Soft Gel Technologies Soft Capsules Drugs CMO Product Market Performance
9.11.4 Soft Gel Technologies Business Overview
9.11.5 Soft Gel Technologies Recent Developments
9.12 Sirio Pharma
9.12.1 Sirio Pharma Soft Capsules Drugs CMO Basic Information
9.12.2 Sirio Pharma Soft Capsules Drugs CMO Product Overview
9.12.3 Sirio Pharma Soft Capsules Drugs CMO Product Market Performance
9.12.4 Sirio Pharma Business Overview
9.12.5 Sirio Pharma Recent Developments
10 SOFT CAPSULES DRUGS CMO MARKET FORECAST BY REGION
10.1 Global Soft Capsules Drugs CMO Market Size Forecast
10.2 Global Soft Capsules Drugs CMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Soft Capsules Drugs CMO Market Size Forecast by Country
10.2.3 Asia Pacific Soft Capsules Drugs CMO Market Size Forecast by Region
10.2.4 South America Soft Capsules Drugs CMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Soft Capsules Drugs CMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Soft Capsules Drugs CMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Soft Capsules Drugs CMO by Type (2025-2030)
11.1.2 Global Soft Capsules Drugs CMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Soft Capsules Drugs CMO by Type (2025-2030)
11.2 Global Soft Capsules Drugs CMO Market Forecast by Application (2025-2030)
11.2.1 Global Soft Capsules Drugs CMO Sales (K Units) Forecast by Application
11.2.2 Global Soft Capsules Drugs CMO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Soft Capsules Drugs CMO Market Size Comparison by Region (M USD)
Table 5. Global Soft Capsules Drugs CMO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Soft Capsules Drugs CMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Soft Capsules Drugs CMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Soft Capsules Drugs CMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Capsules Drugs CMO as of 2022)
Table 10. Global Market Soft Capsules Drugs CMO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Soft Capsules Drugs CMO Sales Sites and Area Served
Table 12. Manufacturers Soft Capsules Drugs CMO Product Type
Table 13. Global Soft Capsules Drugs CMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Soft Capsules Drugs CMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Soft Capsules Drugs CMO Market Challenges
Table 22. Global Soft Capsules Drugs CMO Sales by Type (K Units)
Table 23. Global Soft Capsules Drugs CMO Market Size by Type (M USD)
Table 24. Global Soft Capsules Drugs CMO Sales (K Units) by Type (2019-2024)
Table 25. Global Soft Capsules Drugs CMO Sales Market Share by Type (2019-2024)
Table 26. Global Soft Capsules Drugs CMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Soft Capsules Drugs CMO Market Size Share by Type (2019-2024)
Table 28. Global Soft Capsules Drugs CMO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Soft Capsules Drugs CMO Sales (K Units) by Application
Table 30. Global Soft Capsules Drugs CMO Market Size by Application
Table 31. Global Soft Capsules Drugs CMO Sales by Application (2019-2024) & (K Units)
Table 32. Global Soft Capsules Drugs CMO Sales Market Share by Application (2019-2024)
Table 33. Global Soft Capsules Drugs CMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Soft Capsules Drugs CMO Market Share by Application (2019-2024)
Table 35. Global Soft Capsules Drugs CMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Soft Capsules Drugs CMO Sales by Region (2019-2024) & (K Units)
Table 37. Global Soft Capsules Drugs CMO Sales Market Share by Region (2019-2024)
Table 38. North America Soft Capsules Drugs CMO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Soft Capsules Drugs CMO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Soft Capsules Drugs CMO Sales by Region (2019-2024) & (K Units)
Table 41. South America Soft Capsules Drugs CMO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Soft Capsules Drugs CMO Sales by Region (2019-2024) & (K Units)
Table 43. Catalent Soft Capsules Drugs CMO Basic Information
Table 44. Catalent Soft Capsules Drugs CMO Product Overview
Table 45. Catalent Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Catalent Business Overview
Table 47. Catalent Soft Capsules Drugs CMO SWOT Analysis
Table 48. Catalent Recent Developments
Table 49. Aenova Soft Capsules Drugs CMO Basic Information
Table 50. Aenova Soft Capsules Drugs CMO Product Overview
Table 51. Aenova Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Aenova Business Overview
Table 53. Aenova Soft Capsules Drugs CMO SWOT Analysis
Table 54. Aenova Recent Developments
Table 55. Nature's Bounty Soft Capsules Drugs CMO Basic Information
Table 56. Nature's Bounty Soft Capsules Drugs CMO Product Overview
Table 57. Nature's Bounty Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Nature's Bounty Soft Capsules Drugs CMO SWOT Analysis
Table 59. Nature's Bounty Business Overview
Table 60. Nature's Bounty Recent Developments
Table 61. Procaps Soft Capsules Drugs CMO Basic Information
Table 62. Procaps Soft Capsules Drugs CMO Product Overview
Table 63. Procaps Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Procaps Business Overview
Table 65. Procaps Recent Developments
Table 66. Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Basic Information
Table 67. Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Product Overview
Table 68. Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Patheon (Thermo Fisher Scientific) Business Overview
Table 70. Patheon (Thermo Fisher Scientific) Recent Developments
Table 71. IVC Soft Capsules Drugs CMO Basic Information
Table 72. IVC Soft Capsules Drugs CMO Product Overview
Table 73. IVC Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. IVC Business Overview
Table 75. IVC Recent Developments
Table 76. EuroCaps Soft Capsules Drugs CMO Basic Information
Table 77. EuroCaps Soft Capsules Drugs CMO Product Overview
Table 78. EuroCaps Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. EuroCaps Business Overview
Table 80. EuroCaps Recent Developments
Table 81. Captek Soft Capsules Drugs CMO Basic Information
Table 82. Captek Soft Capsules Drugs CMO Product Overview
Table 83. Captek Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Captek Business Overview
Table 85. Captek Recent Developments
Table 86. Strides Pharma Science Soft Capsules Drugs CMO Basic Information
Table 87. Strides Pharma Science Soft Capsules Drugs CMO Product Overview
Table 88. Strides Pharma Science Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Strides Pharma Science Business Overview
Table 90. Strides Pharma Science Recent Developments
Table 91. Lonza (Capsugel) Soft Capsules Drugs CMO Basic Information
Table 92. Lonza (Capsugel) Soft Capsules Drugs CMO Product Overview
Table 93. Lonza (Capsugel) Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Lonza (Capsugel) Business Overview
Table 95. Lonza (Capsugel) Recent Developments
Table 96. Soft Gel Technologies Soft Capsules Drugs CMO Basic Information
Table 97. Soft Gel Technologies Soft Capsules Drugs CMO Product Overview
Table 98. Soft Gel Technologies Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Soft Gel Technologies Business Overview
Table 100. Soft Gel Technologies Recent Developments
Table 101. Sirio Pharma Soft Capsules Drugs CMO Basic Information
Table 102. Sirio Pharma Soft Capsules Drugs CMO Product Overview
Table 103. Sirio Pharma Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Sirio Pharma Business Overview
Table 105. Sirio Pharma Recent Developments
Table 106. Global Soft Capsules Drugs CMO Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Soft Capsules Drugs CMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Soft Capsules Drugs CMO Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Soft Capsules Drugs CMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Soft Capsules Drugs CMO Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Soft Capsules Drugs CMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Soft Capsules Drugs CMO Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Soft Capsules Drugs CMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Soft Capsules Drugs CMO Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Soft Capsules Drugs CMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Soft Capsules Drugs CMO Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Soft Capsules Drugs CMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Soft Capsules Drugs CMO Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Soft Capsules Drugs CMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Soft Capsules Drugs CMO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Soft Capsules Drugs CMO Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Soft Capsules Drugs CMO Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Soft Capsules Drugs CMO Market Size Comparison by Region (M USD)
Table 5. Global Soft Capsules Drugs CMO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Soft Capsules Drugs CMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Soft Capsules Drugs CMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Soft Capsules Drugs CMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Capsules Drugs CMO as of 2022)
Table 10. Global Market Soft Capsules Drugs CMO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Soft Capsules Drugs CMO Sales Sites and Area Served
Table 12. Manufacturers Soft Capsules Drugs CMO Product Type
Table 13. Global Soft Capsules Drugs CMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Soft Capsules Drugs CMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Soft Capsules Drugs CMO Market Challenges
Table 22. Global Soft Capsules Drugs CMO Sales by Type (K Units)
Table 23. Global Soft Capsules Drugs CMO Market Size by Type (M USD)
Table 24. Global Soft Capsules Drugs CMO Sales (K Units) by Type (2019-2024)
Table 25. Global Soft Capsules Drugs CMO Sales Market Share by Type (2019-2024)
Table 26. Global Soft Capsules Drugs CMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Soft Capsules Drugs CMO Market Size Share by Type (2019-2024)
Table 28. Global Soft Capsules Drugs CMO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Soft Capsules Drugs CMO Sales (K Units) by Application
Table 30. Global Soft Capsules Drugs CMO Market Size by Application
Table 31. Global Soft Capsules Drugs CMO Sales by Application (2019-2024) & (K Units)
Table 32. Global Soft Capsules Drugs CMO Sales Market Share by Application (2019-2024)
Table 33. Global Soft Capsules Drugs CMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Soft Capsules Drugs CMO Market Share by Application (2019-2024)
Table 35. Global Soft Capsules Drugs CMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Soft Capsules Drugs CMO Sales by Region (2019-2024) & (K Units)
Table 37. Global Soft Capsules Drugs CMO Sales Market Share by Region (2019-2024)
Table 38. North America Soft Capsules Drugs CMO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Soft Capsules Drugs CMO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Soft Capsules Drugs CMO Sales by Region (2019-2024) & (K Units)
Table 41. South America Soft Capsules Drugs CMO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Soft Capsules Drugs CMO Sales by Region (2019-2024) & (K Units)
Table 43. Catalent Soft Capsules Drugs CMO Basic Information
Table 44. Catalent Soft Capsules Drugs CMO Product Overview
Table 45. Catalent Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Catalent Business Overview
Table 47. Catalent Soft Capsules Drugs CMO SWOT Analysis
Table 48. Catalent Recent Developments
Table 49. Aenova Soft Capsules Drugs CMO Basic Information
Table 50. Aenova Soft Capsules Drugs CMO Product Overview
Table 51. Aenova Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Aenova Business Overview
Table 53. Aenova Soft Capsules Drugs CMO SWOT Analysis
Table 54. Aenova Recent Developments
Table 55. Nature's Bounty Soft Capsules Drugs CMO Basic Information
Table 56. Nature's Bounty Soft Capsules Drugs CMO Product Overview
Table 57. Nature's Bounty Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Nature's Bounty Soft Capsules Drugs CMO SWOT Analysis
Table 59. Nature's Bounty Business Overview
Table 60. Nature's Bounty Recent Developments
Table 61. Procaps Soft Capsules Drugs CMO Basic Information
Table 62. Procaps Soft Capsules Drugs CMO Product Overview
Table 63. Procaps Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Procaps Business Overview
Table 65. Procaps Recent Developments
Table 66. Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Basic Information
Table 67. Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Product Overview
Table 68. Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Patheon (Thermo Fisher Scientific) Business Overview
Table 70. Patheon (Thermo Fisher Scientific) Recent Developments
Table 71. IVC Soft Capsules Drugs CMO Basic Information
Table 72. IVC Soft Capsules Drugs CMO Product Overview
Table 73. IVC Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. IVC Business Overview
Table 75. IVC Recent Developments
Table 76. EuroCaps Soft Capsules Drugs CMO Basic Information
Table 77. EuroCaps Soft Capsules Drugs CMO Product Overview
Table 78. EuroCaps Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. EuroCaps Business Overview
Table 80. EuroCaps Recent Developments
Table 81. Captek Soft Capsules Drugs CMO Basic Information
Table 82. Captek Soft Capsules Drugs CMO Product Overview
Table 83. Captek Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Captek Business Overview
Table 85. Captek Recent Developments
Table 86. Strides Pharma Science Soft Capsules Drugs CMO Basic Information
Table 87. Strides Pharma Science Soft Capsules Drugs CMO Product Overview
Table 88. Strides Pharma Science Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Strides Pharma Science Business Overview
Table 90. Strides Pharma Science Recent Developments
Table 91. Lonza (Capsugel) Soft Capsules Drugs CMO Basic Information
Table 92. Lonza (Capsugel) Soft Capsules Drugs CMO Product Overview
Table 93. Lonza (Capsugel) Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Lonza (Capsugel) Business Overview
Table 95. Lonza (Capsugel) Recent Developments
Table 96. Soft Gel Technologies Soft Capsules Drugs CMO Basic Information
Table 97. Soft Gel Technologies Soft Capsules Drugs CMO Product Overview
Table 98. Soft Gel Technologies Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Soft Gel Technologies Business Overview
Table 100. Soft Gel Technologies Recent Developments
Table 101. Sirio Pharma Soft Capsules Drugs CMO Basic Information
Table 102. Sirio Pharma Soft Capsules Drugs CMO Product Overview
Table 103. Sirio Pharma Soft Capsules Drugs CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Sirio Pharma Business Overview
Table 105. Sirio Pharma Recent Developments
Table 106. Global Soft Capsules Drugs CMO Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Soft Capsules Drugs CMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Soft Capsules Drugs CMO Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Soft Capsules Drugs CMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Soft Capsules Drugs CMO Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Soft Capsules Drugs CMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Soft Capsules Drugs CMO Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Soft Capsules Drugs CMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Soft Capsules Drugs CMO Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Soft Capsules Drugs CMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Soft Capsules Drugs CMO Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Soft Capsules Drugs CMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Soft Capsules Drugs CMO Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Soft Capsules Drugs CMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Soft Capsules Drugs CMO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Soft Capsules Drugs CMO Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Soft Capsules Drugs CMO Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Soft Capsules Drugs CMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Soft Capsules Drugs CMO Market Size (M USD), 2019-2030
Figure 5. Global Soft Capsules Drugs CMO Market Size (M USD) (2019-2030)
Figure 6. Global Soft Capsules Drugs CMO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Soft Capsules Drugs CMO Market Size by Country (M USD)
Figure 11. Soft Capsules Drugs CMO Sales Share by Manufacturers in 2023
Figure 12. Global Soft Capsules Drugs CMO Revenue Share by Manufacturers in 2023
Figure 13. Soft Capsules Drugs CMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Soft Capsules Drugs CMO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Soft Capsules Drugs CMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Soft Capsules Drugs CMO Market Share by Type
Figure 18. Sales Market Share of Soft Capsules Drugs CMO by Type (2019-2024)
Figure 19. Sales Market Share of Soft Capsules Drugs CMO by Type in 2023
Figure 20. Market Size Share of Soft Capsules Drugs CMO by Type (2019-2024)
Figure 21. Market Size Market Share of Soft Capsules Drugs CMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Soft Capsules Drugs CMO Market Share by Application
Figure 24. Global Soft Capsules Drugs CMO Sales Market Share by Application (2019-2024)
Figure 25. Global Soft Capsules Drugs CMO Sales Market Share by Application in 2023
Figure 26. Global Soft Capsules Drugs CMO Market Share by Application (2019-2024)
Figure 27. Global Soft Capsules Drugs CMO Market Share by Application in 2023
Figure 28. Global Soft Capsules Drugs CMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Soft Capsules Drugs CMO Sales Market Share by Region (2019-2024)
Figure 30. North America Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Soft Capsules Drugs CMO Sales Market Share by Country in 2023
Figure 32. U.S. Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Soft Capsules Drugs CMO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Soft Capsules Drugs CMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Soft Capsules Drugs CMO Sales Market Share by Country in 2023
Figure 37. Germany Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Soft Capsules Drugs CMO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Soft Capsules Drugs CMO Sales Market Share by Region in 2023
Figure 44. China Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Soft Capsules Drugs CMO Sales and Growth Rate (K Units)
Figure 50. South America Soft Capsules Drugs CMO Sales Market Share by Country in 2023
Figure 51. Brazil Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Soft Capsules Drugs CMO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Soft Capsules Drugs CMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Soft Capsules Drugs CMO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Soft Capsules Drugs CMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Soft Capsules Drugs CMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Soft Capsules Drugs CMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Soft Capsules Drugs CMO Sales Forecast by Application (2025-2030)
Figure 66. Global Soft Capsules Drugs CMO Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Soft Capsules Drugs CMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Soft Capsules Drugs CMO Market Size (M USD), 2019-2030
Figure 5. Global Soft Capsules Drugs CMO Market Size (M USD) (2019-2030)
Figure 6. Global Soft Capsules Drugs CMO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Soft Capsules Drugs CMO Market Size by Country (M USD)
Figure 11. Soft Capsules Drugs CMO Sales Share by Manufacturers in 2023
Figure 12. Global Soft Capsules Drugs CMO Revenue Share by Manufacturers in 2023
Figure 13. Soft Capsules Drugs CMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Soft Capsules Drugs CMO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Soft Capsules Drugs CMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Soft Capsules Drugs CMO Market Share by Type
Figure 18. Sales Market Share of Soft Capsules Drugs CMO by Type (2019-2024)
Figure 19. Sales Market Share of Soft Capsules Drugs CMO by Type in 2023
Figure 20. Market Size Share of Soft Capsules Drugs CMO by Type (2019-2024)
Figure 21. Market Size Market Share of Soft Capsules Drugs CMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Soft Capsules Drugs CMO Market Share by Application
Figure 24. Global Soft Capsules Drugs CMO Sales Market Share by Application (2019-2024)
Figure 25. Global Soft Capsules Drugs CMO Sales Market Share by Application in 2023
Figure 26. Global Soft Capsules Drugs CMO Market Share by Application (2019-2024)
Figure 27. Global Soft Capsules Drugs CMO Market Share by Application in 2023
Figure 28. Global Soft Capsules Drugs CMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Soft Capsules Drugs CMO Sales Market Share by Region (2019-2024)
Figure 30. North America Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Soft Capsules Drugs CMO Sales Market Share by Country in 2023
Figure 32. U.S. Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Soft Capsules Drugs CMO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Soft Capsules Drugs CMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Soft Capsules Drugs CMO Sales Market Share by Country in 2023
Figure 37. Germany Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Soft Capsules Drugs CMO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Soft Capsules Drugs CMO Sales Market Share by Region in 2023
Figure 44. China Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Soft Capsules Drugs CMO Sales and Growth Rate (K Units)
Figure 50. South America Soft Capsules Drugs CMO Sales Market Share by Country in 2023
Figure 51. Brazil Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Soft Capsules Drugs CMO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Soft Capsules Drugs CMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Soft Capsules Drugs CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Soft Capsules Drugs CMO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Soft Capsules Drugs CMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Soft Capsules Drugs CMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Soft Capsules Drugs CMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Soft Capsules Drugs CMO Sales Forecast by Application (2025-2030)
Figure 66. Global Soft Capsules Drugs CMO Market Share Forecast by Application (2025-2030)
